EN PL

GMP: New EMA Guideline on Starting Materials from Biological Medicinal Products

22.08.2013
The Guideline describes the requirements for the quality documentation of module 3 of the marketing authorisation dossier. Here, the complete manufacturing process including all sources as well as the relevant safety aspects (i.e. donor controls, virus testing and veterinary investigations) has to be carefully documented.